Best VCs for Health Tech

Co-Founder & Partner

First Round Capital

The seed-stage specialist. Invests earliest and deepest at seed — First Round was one of the firms that pioneered institutional seed investing. Built First Round into a platform that punches well abov

Founding General Partner

Norrsken VC

Agate backs rapidly scalable businesses where solving a major social or environmental problem improves commercial performance. Her finance, fintech-startup and education experience combines with Norrs

Founding General Partner

Norrsken VC

Tove backs ambitious European technology companies whose commercial growth directly improves outcomes for people or planet. Her Bain private-equity background and early impact roles add rigorous marke

Founding Partner & Advisor of Maki.vc

Maki.vc (Web3)

Ilkka co-built Maki around entrepreneurial DNA, technical depth, non-consensus first-round decisions and Nordic founders with global category ambition. His documented portfolio work spans gaming, smar

Head of Events

Lux Capital

Nat designs the convening layer around Lux's frontier-science and technology network. Her work brings together founders, researchers, executives, investors, journalists and creative leaders in focused

Investment Manager

Norrsken VC

Anna combines Norrsken's impact-return mandate with eight years of strategy, operations and international market expansion at Spotify. Her likely value is testing whether an early impact company can t

Chief Financial Officer

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Special Advisor

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Head of Investor Relations

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Associate

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Operations Analyst

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Partner and Fund Manager

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Program Manager

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Operating Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Venture Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Founding Partner

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Founding Member

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Partner

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Chief Scientific Officer

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Managing Partner, GPG Ventures - Houston

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Principal, Investment Operations

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Investment Partner

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Head of Investor Relations

GPG Ventures

At the firm level, GPG Ventures invests nationally in early-stage and growth healthcare and medical technology companies, pairing scientific and operating diligence with fund and portfolio support.

Founder and General Partner

2045 Ventures

Carmen Palafox invests or supports investments through 2045 Ventures's published strategy: Invest early in U.S. technology founders building high-growth companies across fintech, healthtech, climate t

Principal

Karma Ventures

The official roster identifies Ska Sijia Du as Principal. This profile applies Karma Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual ma

Founding Partner

Karma Ventures

The official roster identifies Tommi Uhari as Founding Partner. This profile applies Karma Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individ

Founding Partner

Karma Ventures

The official roster identifies Margus Uudam as Founding Partner. This profile applies Karma Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower indivi

Founding Partner

Karma Ventures

The official roster identifies Kristjan Laanemaa as Founding Partner. This profile applies Karma Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower i

Office Manager

Karma Ventures

The official roster identifies Marianne Kikas as Office Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

Finance Manager

Karma Ventures

The official roster identifies Riin Vähk as Finance Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

Venture Partner

Karma Ventures

The official roster identifies Linda Võeras as Venture Partner. This profile applies Karma Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individ

Managing Partner

Graduate Ventures

The official roster identifies Auke van den Hout as Managing Partner. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrowe

Principal Seed

Graduate Ventures

The official roster identifies Filip Cuypers as Principal Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower indi

Head of Platform

Graduate Ventures

The official roster identifies Julia Knoeff as Head of Platform. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

Principal Seed

Graduate Ventures

The official roster identifies Victor de Leeuw as Principal Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower in

Investor Seed

Graduate Ventures

The official roster identifies Sophie Heijenberg as Investor Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower i

Associate Principal Seed

Graduate Ventures

The official roster identifies Rui Li as Associate Principal Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower i

Head of Pre-Seed Fund

Graduate Ventures

The official roster identifies Eva Post as Head of Pre-Seed Fund. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

Finance Director

Graduate Ventures

The official roster identifies Daan Keizer as Finance Director. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

Investor Pre-Seed

Graduate Ventures

The official roster identifies Maiko Kamerbeek as Investor Pre-Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower

Compliance Officer

Graduate Ventures

The official roster identifies Folkert Mullemeister as Compliance Officer. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

Investor Pre-Seed

Graduate Ventures

The official roster identifies Jasper Wennink as Investor Pre-Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower

Analyst Seed

Graduate Ventures

The official roster identifies Kilian Frunz as Analyst Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individ

Analyst Seed

Graduate Ventures

The official roster identifies Karola Szatmári-Philips as Analyst Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narro

Platform & Events

Graduate Ventures

The official roster identifies Frederique Serrarens as Platform & Events. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

Analyst Pre-Seed

Graduate Ventures

The official roster identifies Gijs Pot as Analyst Pre-Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individ

Analyst Seed

Graduate Ventures

The official roster identifies Karel Jongen as Analyst Seed. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individ

Student Investment Team Member

Graduate Ventures

The official roster identifies Annick Royaards as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority

Student Investment Team Member

Graduate Ventures

The official roster identifies Berend van de Pol as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authorit

Student Investment Team Member

Graduate Ventures

The official roster identifies Evi Vijgeboom as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or

Student Investment Team Member

Graduate Ventures

The official roster identifies Hugo Beentjes as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or

Student Investment Team Member

Graduate Ventures

The official roster identifies Julia d'Hollosy as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority

Student Investment Team Member

Graduate Ventures

The official roster identifies Kas Borstlap as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or

Student Investment Team Member

Graduate Ventures

The official roster identifies Lander Hangelbroek as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authori

Student Investment Team Member

Graduate Ventures

The official roster identifies Maartje Post van der Burg as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing

Student Investment Team Member

Graduate Ventures

The official roster identifies Marijn de Wit as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or

Student Investment Team Member

Graduate Ventures

The official roster identifies Mila den Hollander as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authori

Student Investment Team Member

Graduate Ventures

The official roster identifies Sem Koelewijn as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or

Student Investment Team Member

Graduate Ventures

The official roster identifies Sjoerd Boerema as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority o

Student Investment Team Member

Graduate Ventures

The official roster identifies Tijn de Kruijff as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority

Student Investment Team Member

Graduate Ventures

The official roster identifies Timo Limbourg as Student Investment Team Member. This profile applies Graduate Ventures's published strategy and does not infer undisclosed personal signing authority or

Founding Partner

Nordic Science Investments

Alexandra Gylfe invests or supports investment work through Nordic Science Investments's published strategy: Create and back Nordic university spinouts from incubation through follow-on Series A and B

Founding Partner

Nordic Science Investments

Matti Hautsalo invests or supports investment work through Nordic Science Investments's published strategy: Create and back Nordic university spinouts from incubation through follow-on Series A and B

Founding Partner

Nordic Science Investments

Jari Strandman invests or supports investment work through Nordic Science Investments's published strategy: Create and back Nordic university spinouts from incubation through follow-on Series A and B

Founding Partner

Nordic Science Investments

Anssi Uimonen invests or supports investment work through Nordic Science Investments's published strategy: Create and back Nordic university spinouts from incubation through follow-on Series A and B r

Marketing & Communications

imec.xpand

Tine Nelissen is listed by imec.xpand as Marketing & Communications. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce techno

Principal

Indico Capital

João evaluates Southern European technology companies through a combined engineering, investment-banking, private-equity and venture lens. The documented firm mandate favors globally ambitious founder

Principal

Indico Capital

Rui brings long-running Portuguese institutional venture experience to Indico's early-stage Southern European technology mandate. Public evidence supports a broad rather than narrow personal sector re

Partner

Indico Capital

Rui combines venture investing with transaction and corporate-finance discipline. Within Indico's mandate, that supports globally ambitious Southern European technology companies from early validation

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

General Partner

Hatteras Venture Partners

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Venture Partner

Norrsken Evolve

Siim Teller invests or supports investment work through Norrsken Evolve's published strategy: Back European pre-seed founders building the carbon-free economy and resilient infrastructure, pairing €25

Partner & Co-founder

imec.xpand

Tom Vanhoutte is listed by imec.xpand as Partner & Co-founder. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology r

Partner & Co-founder

imec.xpand

Peter Vanbekbergen is listed by imec.xpand as Partner & Co-founder. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technol

Partner

imec.xpand

Frank Bulens is listed by imec.xpand as Partner. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology risk and accele

Partner

imec.xpand

Cyril Vančura is listed by imec.xpand as Partner. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology risk and accel

Partner

imec.xpand

Bert Gyselinckx is listed by imec.xpand as Partner. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology risk and acc

Partner

imec.xpand

Benoit Devogelaere is listed by imec.xpand as Partner. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology risk and

Principal

imec.xpand

Michael Engelmann is listed by imec.xpand as Principal. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology risk and

Principal

imec.xpand

Jonathan Fajardo Cortes is listed by imec.xpand as Principal. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology ri

Investment Associate

imec.xpand

Moritz Müller is listed by imec.xpand as Investment Associate. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technology r

Portfolio Manager

imec.xpand

Marrit van den Heuvel is listed by imec.xpand as Portfolio Manager. The profile is aligned to the firm's published thesis: Invests where imec expertise and infrastructure can materially reduce technol

Managing Partner

S20 Fund

Marcin Jan Fejfer invests or supports investment work through S20 Fund's published strategy: Back Baltic and Central European technology teams at pre-seed, focusing on essential people-and-planet chal

Investment Analyst and Office Manager

S20 Fund

Łukasz Zięba is listed in a Investment Analyst and Office Manager capacity at S20 Fund. The firm does not publish a person-specific direct-investment mandate for this role; the profile preserves the d

Investment Analyst

S20 Fund

Artur Małuszek invests or supports investment work through S20 Fund's published strategy: Back Baltic and Central European technology teams at pre-seed, focusing on essential people-and-planet challen

Investment Analyst

S20 Fund

Kamil Roszak invests or supports investment work through S20 Fund's published strategy: Back Baltic and Central European technology teams at pre-seed, focusing on essential people-and-planet challenge

General Partner

Norrsken Evolve

Johan Attby invests or supports investment work through Norrsken Evolve's published strategy: Back European pre-seed founders building the carbon-free economy and resilient infrastructure, pairing €25

Platform and Operations

Norrsken Evolve

Merit Vislapu is listed in a Platform and Operations capacity at Norrsken Evolve. The firm does not publish a person-specific direct-investment mandate for this role; the profile preserves the distinc

General Partner

Norrsken Evolve

Rebecka Löthman Rydå invests or supports investment work through Norrsken Evolve's published strategy: Back European pre-seed founders building the carbon-free economy and resilient infrastructure, pa

Analyst

Nordic Science Investments

Hanna Hämäläinen invests or supports investment work through Nordic Science Investments's published strategy: Create and back Nordic university spinouts from incubation through follow-on Series A and

Partner

Nordic Science Investments

Mart Maasik invests or supports investment work through Nordic Science Investments's published strategy: Create and back Nordic university spinouts from incubation through follow-on Series A and B rou

Co-Founder

Norrsken Evolve

Funda Sezgi invests or supports investment work through Norrsken Evolve's published strategy: Back European pre-seed founders building the carbon-free economy and resilient infrastructure, pairing €25

Managing Partner

S20 Fund

Kuba Dudek invests or supports investment work through S20 Fund's published strategy: Back Baltic and Central European technology teams at pre-seed, focusing on essential people-and-planet challenges